Blood pressure control and target organ complications among hypertensive patients in southern Saudi Arabia
AbstractBlood pressure [BP] control and target organ complications [TOC] among 203 hypertensive patients attending a hospital clinic in Abha, Saudi Arabia were studied. Optimal BP control was defined as BP < 140/90 and was achieved in 99 [48.8%] patients. Diuretics and calcium channel blockers were associated with the best rates of BP control while adverse drug reactions were associated with the poorest rates. TOC were classified according to World Health Organization criteria; 62% of patients had no TOC. Retinopathy, renal impairment and left ventricular hypertrophy were the most common stage II complications. Cerebrovascular accidents and ischaemic heart disease were the most common stage III complications
Ahmed, M.E. & El Awad, I.B. (2001). Blood pressure control and target organ complications among hypertensive patients in southern Saudi Arabia. http://www.who.int/iris/handle/10665/119076
EMHJ - Eastern Mediterranean Health Journal, 7 (4-5), 689-696, 2001
MetadataShow full item record
Showing items related by title and MeSH subject.
Risk of hypertension in Yozgat province, central Anatolia: application of framingham hypertension prediction risk score Kilic, M.; Ede, H.; Kilic, A.I. (2016-04)The aim of this cross-sectional study was to estimate the risk of hypertension in 1106 Caucasian individuals aged 20-69 years in Yozgat Province, using the Framingham Hypertension Risk Prediction Score [FHRPS]. According to FHRPS, average risk of developing hypertension over 4 years was 6.2%. The participants were classified into low- [<5%], moderate- [5% to 10%] and high- [>10%] risk groups. The percentage of participants that fell into these groups was 59.4%, 19.8% and 20.8% respectively. The proportion of participants in the high-risk group ...
Использование единиц СИ в медицине: использование килопаскаля для измерения кровяного давления (проект резолюции, предложенный делегациями Финляндии, Федеративной Республики Германии, Ирландии, Италии, Кувейта, Мальты, Новой Зеландии, Свазиленда, Соединенного Королевства Великобритании и Северной Ирландии и Соединенных Штатов Америки) Всемирная ассамблея здравоохранения, 34 сессия (A34/A/Conf.Paper No.2, 1981)